161 related articles for article (PubMed ID: 33888756)
1. Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients.
Peiró CHF; Perez MM; de Aquino GSA; Encinas JFA; Sousa LVA; da Veiga GL; Del Giglio A; Fonseca FLA; da Costa Aguiar Alves B
Sci Rep; 2021 Apr; 11(1):8724. PubMed ID: 33888756
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Chen CL; Chu JS; Su WC; Huang SC; Lee WY
Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
Vitoratou DI; Tolia M; Liakos P; Tsoukalas N; Giaginis C; Nikolaou M; Nikolaou G; Rigas G; Psarianos K; Lioupis A; Kyrgias G
J BUON; 2019; 24(2):456-463. PubMed ID: 31127991
[TBL] [Abstract][Full Text] [Related]
5. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.
Eckert AW; Kappler M; Schubert J; Taubert H
Oral Maxillofac Surg; 2012 Jun; 16(2):189-96. PubMed ID: 22592457
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
7. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
8. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
9. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
[TBL] [Abstract][Full Text] [Related]
10. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
11. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
12. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
13. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
Sousa B; Ribeiro AS; Nobre AR; Lopes N; Martins D; Pinheiro C; Vieira AF; Albergaria A; Gerhard R; Schmitt F; Baltazar F; Paredes J
BMC Cancer; 2014 Oct; 14():734. PubMed ID: 25269858
[TBL] [Abstract][Full Text] [Related]
14. The Hypoxic Response Expression as a Survival Biomarkers in Treatment-Naive Advanced Breast Cancer.
Gunawan I; Hatta M; Benyamin AF; Islam AA
Asian Pac J Cancer Prev; 2020 Mar; 21(3):629-637. PubMed ID: 32212787
[TBL] [Abstract][Full Text] [Related]
15. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Karihtala P; Parkkila S; Saarnio J; Lehenkari PP; Karttunen TJ
APMIS; 2018 Nov; 126(11):852-863. PubMed ID: 30357962
[TBL] [Abstract][Full Text] [Related]
17. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
18. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
19. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
[TBL] [Abstract][Full Text] [Related]
20. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]